Conversely, another study showed that high ERCC1 expression was associated with cisplatin resistance and poor prognosis, while low ERCC1 expression was more sensitive to cisplatin in HNSCC (34). The gene discussed is ERCC1; the disease is head and neck squamous cell carcinoma.